OKUROnKure Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of OnKure Therapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OKUREsta | $107M#8 | — | 0.6x#3 | — | — | -13.0%#10 | — | -34.6%#4 | — | — | -20.2%#1 | — |
| SPRB | $131M#1 | — | 1.6x#6 | — | -100.0%#7 | 26.5%#4 | — | -46.5%#6 | — | — | — | — |
| SCNX | $131M#2 | — | 2.0x#8 | 304.5x#6 | 215.9%#1 | -404.5%#15 | -9867.9%#7 | -64.8%#8 | -73.5%#4 | 4#1 | — | 11.3%#1 |
| CATX | $125M#3 | — | 0.4x#1 | 87.2x#4 | — | -30.1%#12 | -7919.4%#6 | -31.8%#3 | -41.0%#3 | — | — | — |
| FHTX | $119M#4 | — | — | 3.9x#2 | 36.8%#2 | 14.2%#5 | -279.5%#2 | — | — | — | — | — |
| HURA | $116M#5 | — | 6.3x#11 | — | — | -34.8%#13 | — | -167.6%#12 | -0.1%#2 | — | -28.9%#4 | — |
| NERV | $113M#6 | — | — | — | — | -20492.7%#16 | — | — | — | — | -44.0%#5 | — |
| NKTX | $108M#7 | — | 0.4x#2 | — | — | 4.3%#7 | — | -42.0%#5 | — | — | -28.5%#3 | — |
| ANIX | $107M#9 | — | 7.4x#12 | 509.9x#7 | 0.0%#4 | 13.0%#6 | -5571.9%#5 | -75.5%#9 | -87.0%#5 | — | -25.4%#2 | — |
| IMUX | $100M#10 | 3.6x#1 | 0.8x#5 | — | — | 3.3%#8 | — | -76.2%#10 | — | — | — | — |
| ORGO | $95M#11 | — | 0.6x#4 | 0.2x#1 | 17.0%#3 | 4011.1%#1 | 7.9%#1 | 25.0%#1 | 23.2%#1 | — | — | — |
| NRXP | $95M#12 | — | — | 77.4x#3 | — | -13.9%#11 | -1324.4%#3 | — | — | — | — | — |
| GNLX | $94M#13 | — | 5.8x#10 | 11763.8x#8 | 0.0%#4 | -7.6%#9 | -415175.0%#8 | -199.5%#13 | -424.2%#6 | — | — | — |
| UNCY | $94M#14 | — | 1.8x#7 | 139.1x#5 | -29.0%#6 | 27.7%#3 | -4372.9%#4 | -49.8%#7 | — | — | — | — |
| PLYX | $93M#15 | — | 8.5x#13 | — | — | 70.4%#2 | — | -82.1%#11 | — | — | — | — |
| MIST | $92M#16 | — | 5.1x#9 | — | — | -51.9%#14 | — | -0.3%#2 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice